Beginning Wednesday, 12 April 2017 12:00
End Wednesday, 12 April 2017 13:30
Location Pericles Building Rue de la Science 23, 1040, Brussels, Belgium
Event fees British Chamber members: €0.00 (incl. VAT)
Access Members only

As the United Kingdom moves towards initiating the Article 50 procedure the implications of the country's departure from the EU for the pharmaceutical and medical device industries could be substantial. Among the most pressing issues are:

  • What effect will Brexit have for existing and future marketing authorisations for medicinal products
  • How will medical device manufacturers be affected?
  • How does the decision affect commercial contracts?
  • What are the questions you should consider from an IP perspective?
  • Is there anything you should do immediately?
  • How can your businesses influence what happens next?

To RSVP for this event please contact:
Please note places are limited

This event is exclusively open for members.


Sponsor this event

Contact Details:

Payment Instructions:

Wire transfer details
British Chamber of Commerce in Belgium
ING Bank: 310-1391540-64
IBAN: BE29 3101 3915 4064

Not a member yet?

The British Chamber is a membership-driven organisation but is pleased to welcome non-members to sample up to two British Chamber events. Thereafter, we reserve the right to request membership for further attendance of events.

If you’d like to attend this event, please contact us and we’ll be happy to arrange a booking.